Showing results (191-200 of 212) with videos related to
Sort By:
Pageof 22
BMC Nephrology|November 7, 2022
Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING studyDomingo Hernández, Teresa Vázquez-Sánchez, Eugenia Sola, et al.The European Respiratory Journal|August 13, 2021
Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolismDavid Jiménez, Carmen Rodríguez, Francisco León, et al.Epilepsia|January 29, 2013
Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic optionBelén Pérez, Luis González Gutiérrez-Solana, Alfonso Verdú, et al.Journal of Clinical Medicine|July 9, 2020
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-AnalysisJorge García-González, Juan Ruiz-Bañobre, Francisco J Afonso-Afonso, et al.Journal of Clinical Medicine|May 5, 2021
Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant RecipientsDomingo Hernández, Teresa Vázquez, Juana Alonso-Titos, et al.Journal of Clinical Medicine|June 2, 2021
Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant PatientsDomingo Hernández, Juana Alonso-Titos, Teresa Vázquez, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 19, 2024
Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitabilityJonathan R Roth, Travis Rush, Samantha J Thompson, et al.Human Mutation|January 23, 2014
Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patientsAngels García-Cazorla, Alfonso Oyarzabal, Joana Fort, et al.Blood|November 17, 2022
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesisAna Marín-Quílez, Christian Andrea Di Buduo, Lorena Díaz-Ajenjo, et al.Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) studyNicoletta Riva, Laurent Bertoletti, Antonio Chistolini, et al.Pageof 22